Beijing Chunlizhengda Medical Instruments Co., Ltd. provided group earnings guidance for the six months ended 30 June 2019. The board of directors of the Company informed the shareholders of the Company ("Shareholders") and the potential investors that, based on the preliminary assessment with reference to the unaudited management accounts of the Group for the six months ended 30 June 2019, the operating revenue is expected to record a significant increase of more than 50% as compared to that for the corresponding period of last year and the profit recorded a significant increase of more than 70% as compared to that for the corresponding period of last year.